CHA
KURA icon

Carmichael Hill & Associates’s Kura Oncology KURA Stock Holding History

Carmichael Hill & Associates’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$391 Hold
20
– – ﹤0.01% 755
2024
Q2 		$412 Hold
20
– – ﹤0.01% 752
2024
Q1 		$427 Hold
20
– – ﹤0.01% 743
2023
Q4 		$288 Hold
20
– – ﹤0.01% 771
2023
Q3 		$183 Hold
20
– – ﹤0.01% 774
2023
Q2 		$212 Hold
20
– – ﹤0.01% 771
2023
Q1 		$245 Hold
20
– – ﹤0.01% 763
2022
Q4 		$248 Hold
20
– – ﹤0.01% 762
2022
Q3 		$0 Hold
20
– – ﹤0.01% 845
2022
Q2 		$0 Hold
20
– – ﹤0.01% 845
2022
Q1 		$0 Hold
20
– – ﹤0.01% 818
2021
Q4 		$0 Hold
20
– – ﹤0.01% 820
2021
Q3 		$0 Hold
20
– – ﹤0.01% 807
2021
Q2 		$0 Hold
20
– – ﹤0.01% 788
2021
Q1 		$1K Buy
+20
New +$633 ﹤0.01% 740

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carmichael Hill & Associates's KURA Position: Q3 2024 in Review

Carmichael Hill & Associates held its Kura Oncology (KURA) position steady in Q3 2024 at 20 shares worth $391. The position accounts for ﹤0.01% of the portfolio, ranked #755.

Carmichael Hill & Associates first reported a position in KURA in Q1 2021 and has held it in 15 quarters since. The position peaked at $1K in Q1 2021. 179 funds tracked by Wall St. Rank hold KURA as of Q3 2024.

  • Carmichael Hill & Associates held 20 shares of Kura Oncology worth $391 as of Q3 2024.
  • Carmichael Hill & Associates left its Kura Oncology share count unchanged in Q3 2024.
  • Kura Oncology made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #755 holding.
  • Carmichael Hill & Associates first reported a position in Kura Oncology in Q1 2021 and has held it in 15 quarters since.
  • Carmichael Hill & Associates's Kura Oncology position peaked at $1K in Q1 2021.
  • 179 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.